Status:
COMPLETED
Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Diabetes
Metabolic Syndrome
Eligibility:
MALE
30-75 years
Brief Summary
Case control design: lipidomic study in 12 type 2 diabetics with metabolic syndrome, 12 metabolic syndrome without diabetes, 12 subjects with type 1 diabetes and 12 controls
Eligibility Criteria
Inclusion
- statin and fibrate Wash out for one week
- HbA1c\>7% and \<12% (Arms 1 and 3)
- HbA1c\<6% (Arms 2 and 4)
- Metabolic sd according NCEP III (3 out 4 criteria) (Arms 1 and 2)
Exclusion
- secondary CV prevention
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00932087
Start Date
February 1 2009
End Date
January 1 2010
Last Update
April 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fédération d'Endocrinologie-Diabétologie-Maladies métaboliques-Nutrition - Hôpital Cardiovasculaire et Pneumologique
Lyon, France, 69394